• WSJ

    • <h4>WSJ on Facebook</h4><div style="border: none; padding: 2px 3px;" class="fb-like" data-href="http://www.facebook.com/wsj" data-send="false" data-layout="button_count" data-width="250" data-show-faces="false" data-action="recommend"></div>
    • <h4>WSJ on Twitter</h4><a href="https://twitter.com/wsj" class="twitter-follow-button" data-show-count="true">Follow @wsj</a>
  • WSJ LIVE

    • WSJ Live on Facebook

    • WSJ Live on Twitter

  • MARKETWATCH

    • MarketWatch on Facebook

    • MarketWatch on Twitter

  • BARRON'S

    • Barron's on Facebook

    • Barron's on Twitter

  • Portfolio

    • Portfolio on Facebook

    • Portfolio on Twitter

  • DJX

    • Product X on Facebook

    • Product X on Twitter

    • RT
    • F
    • R&C
    • PE&VC
    • WSJ
    • B
  • MORE

    • WSJ Secure
    • BigCharts
    • DJX
    • Portfolio
    • WSJ Live
    • Financial News
    • Professor Journal
    • Student Journal
    • Virtual Stock Exchange
    • WSJ Classifieds
    • WSJ Classrooms
    • WSJ Radio
    • WSJ Wine
The Wall Street Journal
Menu
  • Home
  • World
  • U.S.
  • Business
  • Tech
  • Markets
  • Market Data
  • Your Money
  • Opinion
  • Life & Culture
  • N.Y.
  • Real Estate
  • Management

Also in WSJ.com:

  • Latest News
  • Today's Paper
  • Most Popular
  • Streams (TBD)
  • Video
  • Blogs

International Editions

  • U.S.
  • Asia
  • Europe
  • América Latina
  • Brasil
  • 中文-简体(China)
  • Deutschland
  • India
  • Indonesia
  • 日本(Japan)
  • 한국(Korea)
  • Türkiye
Market Data
  • Log In
  • Subscribe

Genetic Technologies Ltd. ADS GENE (U.S.: Nasdaq)

View All companies
  • AT CLOSE 4:00 PM ET 09/04/14
  • $0.6405 USD
  • -0.0095 -1.46%
  • Volume 219,215
  • Volume 219,215
  • 65 Day Avg Vol 265,689
  • 1 Day Range 0.64 - 0.70
  • 52 Week Range 0.60 - 2.49 (08/25/14 - 10/01/13)
  • 1 Day
  • 5 Day
  • 1 Month
  • 3 Month
  • YTD
  • 1 Year
  • 3 Year
  • $
  • %
Compare
  • Compare to Benchmark:
  • DJIA
  • S&P 500
  • GLOBAL DOW
  • NASDAQ
  • Health Care
  • Compare to
  • Today's Open 0.68
  • Prior Day Close 0.65 (09/03/14)
  • Performance Today
  • GENE -1.46%
  • DJIA -0.05%
  • Russell 2K -0.43%
  • Health Care -0.60%
Company Overview

Latest News Genetic Technologies Ltd. ADS(GENE)

    • 07/07/14
    • Press Release
    Genetic Technologies Provides BREVAGen(TM) Revenue Update for Quarter Ending June 30, 2014
    • Press Release
    • 05/28/14
    • Press Release
    Genetic Technologies Announces Appointment of Chief Financial Officer
    • Press Release
    • 05/16/14
    • Press Release
    Genetic Technologies Announces Completion of Share Transaction With Dr. Mervyn Jacobson
    • Press Release
    • 04/30/14
    • Press Release
    Genetic Technologies Files Activities Report for the Quarter Ended March 31, 2014
    • Press Release
    • 04/17/14
    • Press Release
    Results From Extraordinary General Meeting
    • Press Release
    • 03/24/14
    • Press Release
    Genetic Technologies Executes Agreement With Promega Corporation
    • Press Release
    • 03/07/14
    • Press Release
    Genetic Technologies Announces Publication of Economic Modeling Study Supporting Cost-Effectiveness of BREVAGen(TM) to Direct Tamoxifen Chemoprevention
    • Press Release
    • 02/24/14
    • Press Release
    Genetic Technologies Provides Further Update on Corporate Structure
    • Press Release
    • 02/13/14
    • Dow Jones Newswires
    Genetic Technologies Raised to Buy From Neutral by Ladenburg Thalmann
    • Dow Jones Newswires
    • 02/12/14
    • Press Release
    Genetic Technologies Announces Update on Intellectual Property
    • Press Release
load more
Key Stock Data
?
P/E Ratio (TTM)
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Earnings Per Share (TTM)
A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
Market Capitalization
Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
Shares Outstanding
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Public Float
The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
Dividend Yield
A company's dividend expressed as a percentage of its current stock price.

Key Stock Data

  • P/E Ratio (TTM)
    N/A
  • EPS (TTM)
    $-0.51
  • Market Cap
    $14.36 M
  • Shares Outstanding
    21.24 M
  • Public Float
    N/A
  • Yield
    GENE has not issued dividends in more than 1 year.
  • Latest Dividend
    N/A
  • Ex-Dividend Date
    N/A
?
Shares Sold Short
The total number of shares of a security that have been sold short and not yet repurchased.
Change from Last
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
Percent of Float
Total short positions relative to the number of shares available to trade.

Short Interest

  • Shares Sold Short
    23,809 (08/15/2014)
  • Change from Last
    +102.79%
  • Percent of Float
    N/A
?
Money Flow Uptick/Downtick Ratio
Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

Stock Money Flow

  • Uptick/Downtick Trade Ratio
    0 2
    1.71
    Net Money Flow ($)
    +19,208

    Money flow gives a snapshot of relative buying and selling pressure in a stock. A ratio above one suggests greater buying pressure, below one suggests greater selling.

Advertisement

Competitors (GENE)

Company Change P/E (TTM)
BTX

BioTime Inc.

+1.03% +0.03 -
MBX

Microbix Biosystems Inc.

-3.33% -0.01 24.30
CGEN

Compugen Ltd.

+4.30% +0.40 -
500268

Manali Petrochemicals Ltd.

-2.42% -0.28 6.17
AVH

Avita Medical Ltd.

+2.04% +0.00 -
ROSG

Rosetta Genomics Ltd.

-0.81% -0.03 -
IRSB

Iris Biotechnologies Inc.

+2.86% +0.05 -
BMICY

Bionomics Ltd. ADS

+13.31% +1.31 103.29
AEB

Algae.Tec Ltd.

+1.32% +0.00 -
CLTX

Celsus Therapeutics PLC ADS

-2.52% -0.15 -
  • Competitor Data Provided By: capital cube

Profile (GENE)

Genetic Technologies Ltd. engages in the business of genetic testing services. The company performs a variety of genetic tests on humans and animals which includes human diagnostics, forensics and animal pedigree tests. It operates its business under three segments:...

60-66 Hanover Street
Fitzroy Victoria (VIC) 3065
Australia

  • Website
  • Map
  • Employees -
    Sector Biotechnology
  • Sales or Revenue 4.56 M
    Industry Health Care
  • 1Y Sales Change 35.15%
    Fiscal Year Ends June 30 Download Reports
  • Malcolm Roy Brandon Non-Executive Chairman
  • Alison Jane Mew Chief Executive Officer
  • Diana Newport Director-Quality & Business Operations
  • Eutillio Buccilli Chief Financial Officer
  • More

Research & Ratings Genetic Technologies Ltd. ADS(GENE)

Per-Share Earnings, Actuals and Estimates

GENE will report FY 2015 earnings on false GENE will report Q1 earnings on false
  • Quarterly
  • Annual
Actual Analyst Range Consensus
1.50 1.00 0.50 0.00
N/A
N/A
N/A
N/A
N/A
N/A
Q12014 Q2 Q3 Q4 Q12015 Q2
0.25 0.00 -0.25 -0.50
-0.60
-0.44
-0.22
N/A
FY 2014 FY 2015 FY 2016 FY 2017
Q1 2015 Estimate Trends
Current: $-
1 month ago: $-
3 months ago: $-
Q2 2015 Estimate Trends
Current: $-
1 month ago: $-
3 months ago: $-
FY 2015 Estimate Trends
Current: $-0.44
1 month ago: $-
3 months ago: $-
FY 2016 Estimate Trends
Current: $-0.22
1 month ago: $-
3 months ago: $0.27
  • More

Financials Genetic Technologies Ltd. ADS(GENE)

  • Quarterly
  • Annual

Net Income

0
0 -20M
Jun 2012 Dec 2012 Jun 2013 Dec 2013 Jun 2014
0 30M
0 -30M
'10 '11 '12 '13 '14
Jun 2014 5-quarter trend
Net Income Growth -
Sales or Revenue 2.55 M
Sales or Revenue Growth -
EBITDA -5.22 M
2014 5-year trend
Net Income Growth -8.89%
Sales or Revenue 4.56 M
Sales or Revenue Growth +35.15%
EBITDA -10.74 M
  • More

Notes & Data Providers

Real-time U.S. stock quotes reflect trades reported through Nasdaq only. U.S. stock quote data and real-time U.S. stock indexes provided by Dow Jones.

International stock quotes are delayed as per exchange requirements. Indexes may be real-time or delayed; refer to time stamps on index quote pages for information on delay times.

Quote data, except U.S. stocks, provided by SIX Financial Information.

Data is provided "as is" for informational purposes only and is not intended for trading purposes. SIX Financial Information (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Bond quotes are updated in real-time. Source: Tullett Prebon PLC, ICAP PLC.

Currency quotes are updated in real-time. Source: ICAP PLC.

Advertisement
  • Wall Street Journal
  • Facebook
  • Twitter
  • LinkedIn
  • FourSquare
  • Google+
  • YouTube
  • Podcasts
  • RSS Feed
  • AppStore
  • Subscribe
  • /Login
  • Back to Top«
  • Customer Service

  • Customer Center
  • Contact Us
  • WSJ Weekend
  • Contact Directory
  • Corrections
  • Policy

  • Privacy Policy
  • Cookie Policy
  • Data Policy
  • Copyright Policy
  • Updated :  Subscriber Agreement
    & Terms of Use
  • Your Ad Choices
  • Ads

  • Advertise
  • Place a Classified Ad
  • Sell Your Home
  • Sell Your Business
  • Commercial Real Estate Ads
  • Recruitment & Career Ads
  • Franchising
  • Advertise Locally
  • Tools & Features

  • Apps
  • Emails & Alerts
  • Graphics & Photos
  • Columns
  • Topics
  • Guides
  • Portfolio
  • Old Portfolio
  • More

  • Register for Free
  • Reprints
  • Content Partnerships
  • Conferences
  • Mobile Site
  • News Archive
  • Jobs at WSJ
  • Copyright ©2014 Dow Jones & Company, Inc. All Rights Reserved.